Selected by the Editor-in-Chief | Kidney Cancer Journal, Volume 24(2)
Primary data drawn from ASCO 2026 presentations, JCO supplement abstracts, press releases, and peer-reviewed commentary.
Abstract 1 — LBA418
LITESPARK-022: Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Clear…
ISSN 1933-0863 (PRINT) ISSN 1933-0871 (ONLINE)